Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

JW LIFESCIENCE CORPORATION Logo
Specialized manufacturer of infusion solutions and advanced nutrient IV fluids.
South Korea
234080
JW PHARMACEUTICAL Logo
Develops and commercializes pharmaceuticals, OTC solutions, and nutritional infusions.
South Korea
001060
JW SHINYAK CORPORATION Logo
Develops and sells medicines, specializing in dermatology and urology treatments.
South Korea
067290
Jyong Biotech Ltd. Logo
Develops plant-derived drugs for urinary system diseases, with a drug in Phase III.
United States of America
MENS
kainos loboratories,inc Logo
Develops and manufactures in-vitro diagnostics and clinical testing reagents.
Japan
4556
KAKEN PHARMACEUTIAL CO., LTD. Logo
Develops and markets pharmaceuticals for dermatology, orthopedics, and surgery.
Japan
4521
KALA BIO, Inc. Logo
Clinical-stage biopharma developing therapies for rare and severe eye diseases.
United States of America
KALA
Kalaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing treatments for retinal diseases.
United States of America
KLRS
KalVista Pharmaceuticals, Inc. Logo
Develops oral therapies for rare diseases, with a primary focus on HAE.
United States of America
KALV
Kamada Ltd. Logo
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
Israel
KMDA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.